SCHEMBL6319841

SCHEMBL6319841

COc1cc(C(CNc2cnc3ccccc3c2)P2(=O)NC[C@H](C)[C@@H]2C)cc(OC)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
LMNA P02545 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
GAA P10253 2/20 0.46
NPC1 O15118 2/20 0.46
HPGD P15428 2/20 0.46
HTT P42858 2/20 0.46
RAB9A P51151 2/20 0.46
MAPT P10636 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ALOX12 P18054 1/20 0.40
PDGFRB P09619 1/20 0.37
PDGFRA P16234 1/20 0.37
ALPL P05186 7/20 0.36
GFER P55789 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6317771 0.82 LMNA (0.48) KDM4EALDH1A1LMNASMN1; SMN2GAA
SCHEMBL6317953 0.82 KDM4E (0.46) KDM4EALDH1A1LMNASMN1; SMN2GAA
SCHEMBL6318666 0.80 LMNA (0.46) KDM4EALDH1A1LMNASMN1; SMN2GAA
SCHEMBL6318667 0.80 KDM4E (0.46) KDM4EALDH1A1LMNASMN1; SMN2GAA
SCHEMBL6319838 0.79 KDM4E (0.46) KDM4EALDH1A1LMNASMN1; SMN2GAA
SCHEMBL6323306 0.77 KDM4E (0.47) KDM4EALDH1A1LMNASMN1; SMN2GAA
SCHEMBL6317170 0.76 KDM4E (0.44) KDM4EALDH1A1LMNASMN1; SMN2GAA
SCHEMBL6317168 0.76 KDM4E (0.44) KDM4EALDH1A1LMNASMN1; SMN2GAA
SCHEMBL6317500 0.75 KDM4E (0.45) KDM4EALDH1A1LMNASMN1; SMN2GAA
SCHEMBL6323303 0.73 KDM4E (0.44) KDM4EALDH1A1LMNASMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels QUATRX PHARMACEUTICALS CO. 2005-06-30 US claimed
US-20050142486-A1 Polymers and photoresist compositions comprising same Corless, Peter (US) 2005-06-30 US disclosed
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels QUATRX PHARMACEUTICALS CO. 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels APOB, LDLR, LPL KDM4E 3443/4885ALDH1A1 4526/4885LMNA 144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.